HROWM

Harrow, Inc. - 11.875% Senior Notes due 2027 (HROWM)

About Harrow, Inc. - 11.875% Senior Notes due 2027 (HROWM)

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Details

Daily high

$26.56

Daily low

$26.49

Price at open

$26.50

52 Week High

$27.70

52 Week Low

$24.90

Market cap

Dividend yield

11.19%

Volume

210

Avg. volume

3,808

P/E ratio

Harrow, Inc. - 11.875% Senior Notes due 2027 News